Form 4 for OFIX Orthofix Medical Inc.
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-05 · accession 0000950170-25-034737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 2025-03-05 | OFIX | Calafiore Massimo | Pres, CEO, Dir | P - Purchase | $17.43 | +9,914 | 222.4K | +5% | +$172.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | P | A | 9,914 | $17.43 | 222,404 | D | — | — | (F1) Reflects the weighted average purchase price. The range of prices for these transactions was $17.265 to $17.595. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 182,396 previously reported restricted stock units. |